Adjuvant chemotherapy with oral tegaful and uracil for maxillary sinus carcinoma

Oncology

Volumn 55, Issue 2, 1998, Pages 109-115

  Fujii, Masato ^a,c   Ohno, Yoshihiro ^a   Tokumaru, Yutaka ^a   Imanishi, Yorihisa ^a   Kanke, Minoru ^a   Kanzaki, Jin ^a   Inuyama, Yukio ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Adjuvant chemotherapy; Maxillary sinus carcinoma; Tegaful and uracil

Indexed keywords

TEGAFUR; URACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MAXILLA SINUS CANCER; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MAXILLARY SINUS NEOPLASMS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0031961774     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011844     Document Type: Article

References (15)

1. Giri PGS: Current concepts in therapy cancers of the maxillary sinus. South Med J 1991;84:897-902.
2. Tsujii H, Kamada T, Arimoto T, Mizoe J, Shirato H, Matsuoka Y, Irie G: The role of radiotherapy on the management of maxillary sinus carcinoma. Cancer 1986;57:2261-2266.
3. Sakai S, Hohki A, Fuchihara H, Tanaka Y: Multidisciplinary treatment of maxillary sinus carcinoma. Cancer 1983;52:1360-1364.
4. Stern SJ, Goepfert H, dayman G, Byers R, Ang KK, El-Naggar AK, Wolf P: Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg 1993;119:964-969.
5. Knegt PP, Jong PC, Andel JG, Boer MF, Eykenboom W, Schans E: Carcinoma of the paranasal sinuses. Cancer 1985;56:57-62.
6. Inuyama Y, Fukuda S, Kamata T, Shirato H, Fujii M, Kanazaki J, Horiuchi M: Recent topics in chemotherapy for head and neck cancer; in Cancer Chemotherapy: Challenges for the Future. Tokyo, ExcerptaMedica, 1995, vol. 10, pp 109-117.
7. Ervin T, Clerk R, Weich serbaum R, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987;5:10-20.
8. Kondo M, Ogawa K, Inuyama Y, Yamashita S, Tominaga S, Shigematsu N, Nishiguchi I, Hashimoto S: Prognostic factors influencing relapse of squamous cell carcinoma of the maxillary sinus. Cancer 1985;55:190-196.
9. Fujii S, Ikenaka K, Fukushima M, Shirasaka T: Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and l-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978;69:763-772.
10. Inuyama Y, Fujii M, Mashino S, Tanaka J, Takaoka T, Kohno N: Clinical effect of UFT therapy for head and neck cancer. Jpn J Cancer Chemother 1983;10(1):90-96.
11. Tsukuda M, Ogasawara H, Kanako S, Komiyama S, Horiuchi M, Inuyama Y, Uemura T, Uchida M, Kamata S, Okuda M, Kaneko T, Kumoi T, Sawaki S, Harada Y, Kasuga H, Sugita M, Takeda C, Miyake H: A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Jpn J Cancer Chemother 1994;21:1169-1177.
12. Ota K, Taguchi T, Kimura 12 K: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 1988;22:333-338.
13. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma. Cancer 1987;60:301-311.
14. Jacobs S, Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of head and neck contracts program. 1990;8:838-847.
15. Kondo M, Inuyama Y, Ando Y, Tsutsui T, Yamashita S, Hashimoto T, Kunieda E, Uematsu M, Mashimoto S: Pattern of relapse of squamous cell carcinoma of the maxillary sinus. Cancer 1984;53:2206-2210.